Renal Neoplasms: Kidney Tumors – Types, Symptoms, and Treatment

Renal neoplasms are abnormal growths in the kidney. They range from benign to malignant and vary in clinical significance.

Benign Renal Tumors

  • Angiomyolipoma (AML): Fat-containing; associated with tuberous sclerosis. Risk of hemorrhage if >4 cm.
  • Oncocytoma: Eosinophilic cells; indistinguishable from RCC on imaging; often resected for definitive diagnosis.
  • Simple Cysts: Very common (Bosniak I); no malignant potential.

Malignant: Renal Cell Carcinoma (RCC) – 85–90% of Kidney Cancers

  • Clear Cell (70%): VHL mutation, VEGF-driven; most responsive to targeted therapy.
  • Papillary (10–15%): Type 1 (MET), Type 2 (fumarate hydratase).
  • Chromophobe (5%): Better prognosis.
  • Collecting Duct, Medullary, Translocation: Rare, aggressive.

Presenting Features (Classic Triad: <10% have all three)

  • Hematuria (microscopic or gross)
  • Flank/abdominal pain
  • Palpable mass

Paraneoplastic syndromes: polycythemia (EPO), hypercalcemia (PTHrP), amyloidosis, Stauffer syndrome (hepatic dysfunction).

Staging & Treatment

StageTreatment
I–II (localized)Partial nephrectomy (nephron-sparing) preferred; radical if not feasible. Ablation (RFA/cryo) for small tumors in poor surgical candidates.
III (locally advanced)Radical nephrectomy ± lymphadenectomy; adjuvant pembrolizumab (KEYNOTE-564) for high-risk clear cell.
IV (metastatic)Systemic therapy: VEGF TKIs (sunitinib, pazopanib, cabozantinib) + IO (nivolumab/ipilimumab, pembrolizumab/axitinib). Cytoreductive nephrectomy selected cases.

Multidisciplinary tumor board guides complex decisions. Surveillance imaging critical for recurrence detection.

Kidney Disease - Related Articles